器官移植排斥药物市场 - 按药物类别（钙调磷酸酶抑制剂、抗体、抗增殖剂）、移植类型（肾臟、肝臟、心臟）、配销通路（医院、零售药房）、全球预测，2023-2032 年

由于慢性病发病率不断上升以及器官移植的必要性不断增加，预计 2023 年至 2032 年器官移植排斥药物市场规模将以 3.2% 的复合年增长率扩大。与生活方式相关的疾病的涌入以及终末期肾病和肝衰竭等疾病负担的增加，导致对有效排斥药物的需求激增。

此外，医疗保健提供者越来越重视优化患者的治疗结果，以及不断开发针对器官排斥的创新免疫抑制疗法，这将推动市场的成长。举个例子，2023 年 9 月，Eledon Pharmaceuticals, Inc. 透露，在第二次猪基因工程心臟移植后，其实验性抗 CD40 抗体 tegoprubart 被用作慢性免疫抑制治疗的关键成分对一个人。

器官移植排斥药物产业依移植类型、配销通路、药品类别和地区分类。

预计抗体药物类别的市场份额将在 2023 年至 2032 年间获得显着增长。全球器官移植手术数量的激增正在推动对有效免疫抑制疗法的需求，以确保改善患者的治疗结果。最近，提供增强特异性和减少不良反应的抗体已获得广泛关注。此外，正在进行的专注于优化抗体疗法的研发计划将支持该细分市场的成长。

根据配销通路，预计到 2032 年，零售药房领域的器官移植排斥药物市场将实现强劲增长。广泛的零售药房网络及其可及性和以患者为中心的方法将极大地促进器官排斥药物的分销。此外，对个人化咨询和药物管理服务的需求不断增长，导致器官移植排斥药物的使用增加。

从地区来看，由于器官移植手术日益普及和慢性病发病率上升，预计到 2032 年，亚太地区器官移植排斥药物产业将大幅成长。大规模的医疗保健投资和医疗基础设施的进步导致对有效的免疫抑制疗法以防止移植排斥的需求不断增长。此外，大量患者的存在以及政府加强医疗保健支持性措施的实施将增强该地区的行业前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：器官移植排斥药物市场洞察

• 产业格局
• 产业影响力
  • 成长动力
    • 由于慢性病而增加的器官移植手术
    • 器官移植和组织工程的技术进步
  • 产业陷阱与挑战
    • 器官移植手术费用高
    • 可移植器官的可用性低
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪錶板

第 5 章：器官移植排斥药物市场估计与预测：按药物类别，2018 - 2032

• 主要动向：依药物类别
• 钙调磷酸酶抑制剂
• 抗体
• 抗增殖剂
• mTOR抑制剂
• 类固醇

第 6 章：器官移植排斥药物市场估计与预测：按移植类型，2018 - 2032

• 主要动向：依移植类型
• 肾
• 肝
• 心
• 肺
• 胰臟
• 其他移植类型

第 7 章：器官移植排斥药物市场估计与预测：按配销通路，2018 - 2032

• 主要动向：按配销通路
• 医院药房
• 零售药局
• 网路药局

第 8 章：器官移植排斥药物市场估计与预测：按地区，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 瑞士
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Astellas Pharma Inc.
• Sanofi
• Bristol-Myers Squibb Company
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Accord Healthcare Ltd
• Viatris, Inc.
• Dr. Reddy's Laboratories Ltd
• Veloxis Pharmaceuticals A/S
• GlaxoSmithKline plc

Organ Transplant Rejection Medication Market size is projected to expand at 3.2% CAGR from 2023-2032 attributed to the escalating frequency of chronic diseases and the rising necessity of organ transplants. The influx of lifestyle-related ailments and the growing burden of conditions, such as end-stage renal disease and liver failure are contributing to the surging demand for effective rejection medications.

Moreover, the scaling emphasis of healthcare providers on optimizing patient outcomes along with the continuous development of innovative immunosuppressive therapies tailored to combat organ rejection will fuel the market growth. To cite an instance, in September 2023, Eledon Pharmaceuticals, Inc. revealed that tegoprubart, its experimental anti-CD40 antibody, was employed as a key component in the chronic immunosuppressive treatment after the second-ever transplant of a genetically engineered heart from a pig to a person.

The organ transplant rejection medication industry is categorized by transplant type, distribution channel, drug class, and region.

The market share from the antibodies drug class segment is anticipated to gain significant traction between 2023 and 2032. The surging number of organ transplantation procedures across the globe is driving the need for effective immunosuppressive therapies to ensure improved patient outcomes. Of late, antibodies offering enhanced specificity and reduced adverse effects have gained widespread prominence. Additionally, the ongoing R&D initiatives focused on optimizing antibody-based therapies will support the segment growth.

Based on distribution channel, the organ transplant rejection medication market from the retail pharmacies segment is anticipated to record robust growth through 2032. The widespread network of retail pharmacies coupled with their accessibility and patient-centric approach are significantly facilitating the distribution of organ rejection medications. Furthermore, the rising need for personalized counseling and medication management services is contributing to the increased uptake of organ transplant rejection medications.

Regionally, the Asia Pacific organ transplant rejection medication industry is estimated to witness substantial growth through 2032, propelled by the increasing prevalence of organ transplantation procedures and the rising incidence of chronic diseases. Massive healthcare investments and advancements in medical infrastructure are contributing to the growing demand for effective immunosuppressive therapies to prevent transplant rejection. Moreover, the presence of large patient pool and the higher implementation of supportive government initiatives to enhance healthcare access will augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Organ transplant rejection medication industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Drug class trends
  • 2.1.4 Transplant type trends
  • 2.1.5 Distribution channel trends

Chapter 3 Organ Transplant Rejection Medication Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing organ transplant procedures due to chronic diseases
    • 3.2.1.2 Technological advancements in organ transplantation and tissue engineering
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of organ transplantation procedures
    • 3.2.2.2 Low availability of organs for transplantation
• 3.3 Growth potential analysis
  • 3.3.1 By drug class
  • 3.3.2 By transplant type
  • 3.3.3 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic dashboard, 2022

Chapter 5 Organ Transplant Rejection Medication Market Estimates and Forecast, By Drug Class, 2018 - 2032 (USD Million)

• 5.1 Key trends, by drug class
• 5.2 Calcineurin inhibitors
• 5.3 Antibodies
• 5.4 Antiproliferative agents
• 5.5 mTOR inhibitor
• 5.6 Steroids

Chapter 6 Organ Transplant Rejection Medication Market Estimates and Forecast, By Transplant Type, 2018 - 2032 (USD Million)

• 6.1 Key trends, by transplant type
• 6.2 Kidney
• 6.3 Liver
• 6.4 Heart
• 6.5 Lung
• 6.6 Pancreas
• 6.7 Other transplant types

Chapter 7 Organ Transplant Rejection Medication Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Hospital pharmacies
• 7.3 Retail pharmacies
• 7.4 Online pharmacies

Chapter 8 Organ Transplant Rejection Medication Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Switzerland
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Astellas Pharma Inc.
• 9.2 Sanofi
• 9.3 Bristol-Myers Squibb Company
• 9.4 Novartis AG
• 9.5 F. Hoffmann-La Roche Ltd
• 9.6 Accord Healthcare Ltd
• 9.7 Viatris, Inc.
• 9.8 Dr. Reddy's Laboratories Ltd
• 9.9 Veloxis Pharmaceuticals A/S
• 9.10 GlaxoSmithKline plc

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug class (2022)
• TABLE 3 Market revenue, by transplant type (2022)
• TABLE 4 Market revenue, by distribution channel (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global organ transplant rejection medicine market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global organ transplant rejection medicine market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 9 Global organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 10 Global organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 11 Global organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 12 Global organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 13 Global organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 14 Industry impact forces
• TABLE 15 Competitive benchmarking of major market players
• TABLE 16 Competitive positioning matrix: Classification criteria
• TABLE 17 Strategic outlook matrix: Classification criteria
• TABLE 18 Calcineurin inhibitors market size, by region, 2018 - 2022 (USD Million)
• TABLE 19 Calcineurin inhibitors market size, by region, 2023 - 2032 (USD Million)
• TABLE 20 Antibodies market size, by region, 2018 - 2022 (USD Million)
• TABLE 21 Antibodies market size, by region, 2023 - 2032 (USD Million)
• TABLE 22 Antiproliferative agents market size, by region, 2018 - 2022 (USD Million)
• TABLE 23 Antiproliferative agents market size, by region, 2023 - 2032 (USD Million)
• TABLE 24 mTOR inhibitor market size, by region, 2018 - 2022 (USD Million)
• TABLE 25 mTOR inhibitor market size, by region, 2023 - 2032 (USD Million)
• TABLE 26 Steroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 27 Steroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 28 Kidney market size, by region, 2018 - 2022 (USD Million)
• TABLE 29 Kidney market size, by region, 2023 - 2032 (USD Million)
• TABLE 30 Liver market size, by region, 2018 - 2022 (USD Million)
• TABLE 31 Liver market size, by region, 2023 - 2032 (USD Million)
• TABLE 32 Heart market size, by region, 2018 - 2022 (USD Million)
• TABLE 33 Heart market size, by region, 2023 - 2032 (USD Million)
• TABLE 34 Lung market size, by region, 2018 - 2022 (USD Million)
• TABLE 35 Lung market size, by region, 2023 - 2032 (USD Million)
• TABLE 36 Pancreas market size, by region, 2018 - 2022 (USD Million)
• TABLE 37 Pancreas market size, by region, 2023 - 2032 (USD Million)
• TABLE 38 Other transplant types market size, by region, 2018 - 2022 (USD Million)
• TABLE 39 Other transplant types market size, by region, 2023 - 2032 (USD Million)
• TABLE 40 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 41 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 42 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 43 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 44 Online pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 45 Online pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 46 North America organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
• TABLE 47 North America organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
• TABLE 48 North America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 49 North America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 50 North America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 51 North America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 52 North America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 53 North America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 54 U.S. organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 55 U.S. organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 56 U.S. organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 57 U.S. organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 58 U.S. organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 59 U.S. organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 60 Canada organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 61 Canada organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 62 Canada organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 63 Canada organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 64 Canada organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 65 Canada organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 66 Europe organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
• TABLE 67 Europe organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
• TABLE 68 Europe organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 69 Europe organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 70 Europe organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 71 Europe organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 72 Europe organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 73 Europe organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 74 Germany organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 75 Germany organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 76 Germany organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 77 Germany organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 78 Germany organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 79 Germany organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 80 UK organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 81 UK organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 82 UK organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 83 UK organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 84 UK organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 85 UK organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 86 France organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 87 France organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 88 France organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 89 France organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 90 France organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 91 France organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 92 Spain organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 93 Spain organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 94 Spain organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 95 Spain organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 96 Spain organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 97 Spain organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 98 Italy organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 99 Italy organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 100 Italy organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 101 Italy organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 102 Italy organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 103 Italy organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 104 Switzerland organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 105 Switzerland organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 106 Switzerland organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 107 Switzerland organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 108 Switzerland organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 109 Switzerland organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 110 Rest of Europe organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 111 Rest of Europe organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 112 Rest of Europe organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 113 Rest of Europe organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 114 Rest of Europe organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 115 Rest of Europe organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 116 Asia Pacific organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
• TABLE 117 Asia Pacific organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
• TABLE 118 Asia Pacific organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 119 Asia Pacific organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 120 Asia Pacific organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 121 Asia Pacific organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 122 Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 123 Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 124 China organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 125 China organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 126 China organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 127 China organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 128 China organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 129 China organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 130 Japan organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 131 Japan organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 132 Japan organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 133 Japan organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 134 Japan organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 135 Japan organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 136 India organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 137 India organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 138 India organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 139 India organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 140 India organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 141 India organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 142 Australia organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 143 Australia organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 144 Australia organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 145 Australia organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 146 Australia organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 147 Australia organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 148 South Korea organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 149 South Korea organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 150 South Korea organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 151 South Korea organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 152 South Korea organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 153 South Korea organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 154 Rest of Asia Pacific organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 155 Rest of Asia Pacific organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 156 Rest of Asia Pacific organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 157 Rest of Asia Pacific organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 158 Rest of Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 159 Rest of Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 160 Latin America organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
• TABLE 161 Latin America organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
• TABLE 162 Latin America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 163 Latin America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 164 Latin America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 165 Latin America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 166 Latin America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 167 Latin America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 168 Brazil organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 169 Brazil organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 170 Brazil organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 171 Brazil organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 172 Brazil organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 173 Brazil organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 174 Mexico organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 175 Mexico organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 176 Mexico organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 177 Mexico organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 178 Mexico organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 179 Mexico organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 180 Rest of Latin America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 181 Rest of Latin America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 182 Rest of Latin America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 183 Rest of Latin America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 184 Rest of Latin America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 185 Rest of Latin America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 186 Middle East & Africa organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
• TABLE 187 Middle East & Africa organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
• TABLE 188 Middle East & Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 189 Middle East & Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 190 Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 191 Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 192 Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 193 Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 194 South Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 195 South Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 196 South Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 197 South Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 198 South Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 199 South Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 200 Saudi Arabia organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 201 Saudi Arabia organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 202 Saudi Arabia organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 203 Saudi Arabia organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 204 Saudi Arabia organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 205 Saudi Arabia organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 206 Rest of Middle East & Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 207 Rest of Middle East & Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 208 Rest of Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
• TABLE 209 Rest of Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
• TABLE 210 Rest of Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 211 Rest of Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Organ transplant rejection medicine industry 36 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by drug class
• FIG 8 Growth potential analysis, by transplant type
• FIG 9 Growth potential analysis, by distribution channel
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Global company market share analysis, 2022
• FIG 14 Competitive positioning matrix, 2022
• FIG 15 Strategic dashboard, 2022